BRAF GENE MUTATION
Clinical trials for BRAF GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new BRAF GENE MUTATION trials appear
Sign up with your email to follow new studies for BRAF GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer drug trial halted early after 29 patients
Disease control TerminatedThis early-phase trial tested a new drug, DCC-3084, alone or with other treatments, in people with advanced solid tumors linked to MAPK pathway mutations (like certain lung, pancreatic, or skin cancers). The study aimed to find safe doses and check if tumors shrank. It was termin…
Matched conditions: BRAF GENE MUTATION
Phase: PHASE1 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated May 26, 2026 05:56 UTC
-
New cancer pill shows promise in early trial, but study halted
Disease control TerminatedThis early-phase study tested an experimental oral drug called IK-595 in 75 adults with advanced solid tumors (like colorectal, pancreatic, or lung cancer) that have specific RAS or RAF gene mutations and no standard treatment options left. The goal was to check the drug's safety…
Matched conditions: BRAF GENE MUTATION
Phase: PHASE1 • Sponsor: Ikena Oncology • Aim: Disease control
Last updated May 22, 2026 14:03 UTC